Evidence map›Paper›PMID 42427232›Full record

ArticleJournal of medicinal chemistry2026

Discovery of Novel Synthetic Cyclohexene-Based Small Molecules Targeting Senescence against Age-Related Pulmonary Fibrosis.

Iván Arribas-Álvarez, Sergio Algar, Pilar Picallos-Rabina, Anabel Sánchez-Merino, Beatriz Marcos-Ramiro, Manuel Collado, Henar Vázquez-Villa, María L López-Rodríguez, Bellinda Benhamú

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Iván Arribas-ÁlvarezDepartment of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, E-28040 Madrid, Spain.
Sergio AlgarDepartment of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, E-28040 Madrid, Spain.ORCID 0000-0003-0933-5985
Pilar Picallos-RabinaLaboratory of Cell Senescence, Cancer and Aging, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), E-15706 Santiago de Compostela, Spain.
Anabel Sánchez-MerinoDepartment of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, E-28040 Madrid, Spain.
Beatriz Marcos-RamiroDepartment of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, E-28040 Madrid, Spain.
Manuel ColladoLaboratory of Cell Senescence, Cancer and Aging, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), E-15706 Santiago de Compostela, Spain.
Henar Vázquez-VillaDepartment of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, E-28040 Madrid, Spain.ORCID 0000-0001-7911-3160
María L López-RodríguezDepartment of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, E-28040 Madrid, Spain.ORCID 0000-0001-8607-1085
Bellinda BenhamúDepartment of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, E-28040 Madrid, Spain.ORCID 0000-0002-0864-026X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeting cellular senescence has emerged as a therapeutic strategy for the increasingly prevalent age-related diseases, yet no drugs have reached clinical approval specifically as senotherapeutics. Through senescence-phenotype screening of our recently generated human microbiota-inspired library of small molecules, we identified a tetrasubstituted cyclohexene as a novel bioactive chemotype. Following the synthesis of related analogues and their evaluation in relevant models of senescence, we discovered compound

Indexed as

Cellular SenescenceCyclohexenesDrug DiscoveryPulmonary FibrosisSenotherapeuticsSmall Molecule LibrariesAgingAnimalsbeta-GalactosidaseCell ProliferationFibroblastsHumansMiceStructure-Activity Relationshipbeta-GalactosidasecyclohexeneCyclohexenesSenotherapeuticsSmall Molecule Libraries

Identifiers

PMID42427232
PMCPMC13403236

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.